Corcept Therapeutics Incorporated Capital Reinvestment Ratio
Corcept Therapeutics Incorporated capital reinvestment ratio. Corcept Therapeutics Incorporated (CORT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($38.45 Million) in capital expenditures ($50.00K). Check how aggressively does Corcept Therapeutics Incorporated reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Corcept Therapeutics Incorporated (2015–2025)
Capital reinvestment ratio of Corcept Therapeutics Incorporated from 2015 to 2025. This chart tracks Corcept Therapeutics Incorporated's Capital Reinvestment Ratio across 11 annual periods. Also explore how fast is Corcept Therapeutics Incorporated growing its equity to track the company's year-over-year net asset growth rate.
Corcept Therapeutics Incorporated Capital Reinvestment Ratio by Year (2015–2025)
Corcept Therapeutics Incorporated capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see CORT cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $142.00 Million | $211.00K | ▼ -86.4% |
| 2024 | 0.01x | $198.07 Million | $2.17 Million | ▲ +902.2% |
| 2023 | 0.00x | $127.04 Million | $139.00K | ▼ -68.1% |
| 2022 | 0.00x | $120.32 Million | $413.00K | ▲ +22.9% |
| 2021 | 0.00x | $167.89 Million | $469.00K | ▼ -65.7% |
| 2020 | 0.01x | $151.97 Million | $1.24 Million | ▲ +1.9% |
| 2019 | 0.01x | $136.12 Million | $1.09 Million | ▲ +210.2% |
| 2018 | 0.00x | $115.67 Million | $298.00K | ▼ -62.5% |
| 2017 | 0.01x | $60.94 Million | $419.00K | ▼ -34.8% |
| 2016 | 0.01x | $18.39 Million | $194.00K | ▲ +94.2% |
| 2015 | 0.01x | $3.13 Million | $17.00K | — |